SHPH·825693401·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
SHPH (SHUTTLE PHARMACTCLS HLDGS IN) is held by 4 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($31,371), UBS Group AG ($3,850), MORGAN STANLEY ($18). Net institutional sentiment: Mixed.
See how SHPH's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer